Replies to post #211068 on Biotech Values

[bladerunner1717]

Oppenheimer initiates coverage of MEIP with "outperform." Stock up 9%

Oppenheimer initiated coverage on MEI Pharma Inc
MEIP
with an Outperform rating. The price target for MEI Pharma is set to $6.50. MEI Pharma shares closed at $1.67 on Wednesday.


Bladerunner